Cisplatin: a Review of Clinical Applications and Renal Toxicity

Overview

Journal Pharm Weekbl Sci

Specialty Pharmacy

Date 1985 Dec 13

PMID 3909096

Citations 12

Authors

D T Sleijfer

S Meijer

N H Mulder

Affiliations

Soon will be listed here.

Abstract

In reviewing the literature about the clinical application of cis-diamminedichloroplatinum(II) (cisplatin) it can be concluded that the availability of cisplatin has been an important advance in cancer chemotherapy; especially in patients with disseminated testicular carcinoma and ovarian cancer cisplatin-based combinations are the first choice treatment. Our own investigations of the nature of the main form of toxicity of cisplatin, the nephrotoxicity, are mentioned and methods of its prevention are summarized.

Citing Articles

Protective Effect of Rutin Trihydrate Against Dose-Dependent, Cisplatin-Induced Cardiac Toxicity in Isolated Perfused Rat's Heart.

Bukhari I, Mohamed O, Alhowikan A, Lateef R, Hagar H, Assiri R Cureus. 2022; 14(1):e21572.

PMID: 35228931 PMC: 8866754. DOI: 10.7759/cureus.21572.

Ultrasound image-guided therapy enhances antitumor effect of cisplatin.

Sasaki N, Kudo N, Nakamura K, Lim S, Murakami M, Kumara W J Med Ultrason (2001). 2016; 41(1):11-21.

PMID: 27277628 DOI: 10.1007/s10396-013-0475-y.

Inhibition of autophagy using 3-methyladenine increases cisplatin-induced apoptosis by increasing endoplasmic reticulum stress in U251 human glioma cells.

Zhang R, Wang R, Chen Q, Chang H Mol Med Rep. 2015; 12(2):1727-32.

PMID: 25846607 PMC: 4464427. DOI: 10.3892/mmr.2015.3588.

A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living mice.

Godinat A, Park H, Miller S, Cheng K, Hanahan D, Sanman L ACS Chem Biol. 2013; 8(5):987-99.

PMID: 23463944 PMC: 3836283. DOI: 10.1021/cb3007314.

A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity.

Nasiri-Toosi Z, Dashti-Khavidaki S, Khalili H, Lessan-Pezeshki M Eur J Clin Pharmacol. 2012; 69(5):1057-73.

PMID: 23179178 DOI: 10.1007/s00228-012-1452-x.

References

Speer R, Ridgway H, Hall L, Stewart D, Howe K, Lieberman D . Coordination complexes of platinum as antitumor agents. Cancer Chemother Rep. 1975; 59(3):629-41. View

Elwood C, SIGMAN E . The measurement of glomerular filtration rate and effective renal plasma flow in man by iothalamate 125-I and iodopyracet 131-I. Circulation. 1967; 36(3):441-8. DOI: 10.1161/01.cir.36.3.441. View

Hong W, Schaefer S, Issell B, Cummings C, Luedke D, Bromer R . A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck. Cancer. 1983; 52(2):206-10. DOI: 10.1002/1097-0142(19830715)52:2<206::aid-cncr2820520204>3.0.co;2-j. View

Klastersky J, Longeval E, Nicaise C, Weerts D . Etoposide and cis-platinum in non-small-cell bronchogenic carcinoma. Cancer Treat Rev. 1982; 9 Suppl:133-8. DOI: 10.1016/s0305-7372(82)80092-3. View

Schaefer S, Middleton R, Reisch J, Frenkel E . Cis-platinum induction chemotherapy in the multi-modality initial treatment of advanced stage IV carcinoma of the head and neck. Cancer. 1983; 51(12):2168-74. DOI: 10.1002/1097-0142(19830615)51:12<2168::aid-cncr2820511204>3.0.co;2-h. View

Schilsky R, Anderson T . Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin. Ann Intern Med. 1979; 90(6):929-31. DOI: 10.7326/0003-4819-90-6-929. View

Neijt J, Ten Bokkel Huinink W, van der Burg M, Van Oosterom A, Vriesendorp R, Pinedo H . Current status of systemic chemotherapy in the treatment of advanced ovarian cancer with emphasis on CHAP-5. Radiother Oncol. 1984; 2(1):19-29. DOI: 10.1016/s0167-8140(84)80034-1. View

York R, Lawson D, McKay J . Treatment of metastatic malignant melanoma with vinblastine, bleomycin by infusion and cisplatin. Cancer. 1983; 52(12):2220-2. DOI: 10.1002/1097-0142(19831215)52:12<2220::aid-cncr2820521208>3.0.co;2-p. View

NATHANSON L, Kaufman S, Carey R . Vinblastine, infusion, bleomycin, and cis-dichlorodiammine-platinum chemotherapy in metastatic melanoma. Cancer. 1981; 48(6):1290-4. DOI: 10.1002/1097-0142(19810915)48:6<1290::aid-cncr2820480605>3.0.co;2-1. View

10.

Denis L . Anaphylactic reactions to repeated intravesical instillation with cisplatin. Lancet. 1983; 1(8338):1378-9. DOI: 10.1016/s0140-6736(83)92153-0. View

11.

Offerman J, Mulder N, Sleijfer D, Meijer S, Koops H, Donker A . Influence of captopril on cis-diamminedichloroplatinum-induced renal toxicity. Am J Nephrol. 1985; 5(6):433-6. DOI: 10.1159/000166978. View

12.

Meijer S, Mulder N, Sleijfer D, Donker A, Sluiter W, de Jong P . Influence of combination chemotherapy with cis-diamminedichloroplatinum on renal function: long-term effects. Oncology. 1983; 40(3):170-3. DOI: 10.1159/000225718. View

13.

Wittes R, Cvitkovic E, Shah J, GEROLD F, Strong E . CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck. Cancer Treat Rep. 1977; 61(3):359-66. View

14.

Ochs J, Freeman A, Douglass Jr H, Higby D, Mindell E, Sinks L . cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma. Cancer Treat Rep. 1978; 62(2):239-45. View

15.

Stark J, Howel S . Nephrotoxicity of cis-platinum (II) dichlorodiammine. Clin Pharmacol Ther. 1978; 23(4):461-6. DOI: 10.1002/cpt1978234461. View

16.

Hayes D, Cvitkovic E, Sternberg S . Acute renal failure after cis-dichlorodiammineplatinum(II) and gentamicin-cephalothin therapies. Cancer Treat Rep. 1978; 62(5):693-8. View

17.

Williams S, Einhorn L . Etoposide salvage therapy for refractory germ cell tumors: an update. Cancer Treat Rev. 1982; 9 Suppl:67-71. DOI: 10.1016/s0305-7372(82)80081-9. View

18.

Blachley J, Hill J . Renal and electrolyte disturbances associated with cisplatin. Ann Intern Med. 1981; 95(5):628-32. DOI: 10.7326/0003-4819-95-5-628. View

19.

Choie D, Longnecker D, del Campo A . Acute and chronic cisplatin nephropathy in rats. Lab Invest. 1981; 44(5):397-402. View

20.

Al-Sarraf M, Fletcher W, Oishi N, Pugh R, HEWLETT J, Balducci L . Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study. Cancer Treat Rep. 1982; 66(1):31-5. View